Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers

Vaccine. 2017 May 2;35(19):2558-2568. doi: 10.1016/j.vaccine.2017.03.063. Epub 2017 Apr 3.

Abstract

Objective: To compare the antibody response to influenza between health care workers (HCWs) who have received multiple vaccinations (high vaccination group) and those who have received fewer vaccinations (low vaccination group).

Design: Prospective serosurvey.

Setting: Tertiary referral hospital.

Participants: Healthcare workers.

Methods: Healthcare workers were vaccinated with the 2015 southern hemisphere trivalent influenza vaccine. Influenza antibody titres were measured pre-vaccination, 21-28days post-vaccination and 6months post-vaccination. Antibody titres were measured using the haemagglutination inhibition assay. Levels of seropositivity and estimated geometric mean titres were calculated.

Results: Of the 202 HCWs enrolled, 182 completed the study (143 high vaccination and 39 low vaccination). Both vaccination groups demonstrated increases in post-vaccination geometric mean titres, with greater gains in the low vaccination group. Seropositivity remained high in both high and low vaccination groups post-vaccination. The highest fold rise was observed among HCWs in the low vaccination group against the H3N2 component of the vaccine.

Conclusions: Both high and low vaccination groups in our study demonstrated protective antibody titres post-vaccination. The findings from the current study are suggestive of decreased serological response among highly vaccinated HCWs. More studies with larger sample sizes and a greater number of people in the vaccine-naïve and once-vaccinated groups are required to confirm or refute these findings before making any policy changes.

Keywords: Antibody; Focus reduction assay; Healthcare worker; Hemagglutination inhibition assay; Immunogenicity; Influenza vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood*
  • Antibody Formation
  • Female
  • Health Personnel*
  • Humans
  • Immunization, Secondary*
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / immunology*
  • Influenza, Human / prevention & control*
  • Male
  • Middle Aged
  • Prospective Studies
  • Tertiary Care Centers
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Viral
  • Influenza Vaccines